Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Capital Expenditures (2021 - 2026)

Core Scientific has reported Capital Expenditures over the past 6 years, most recently at $389.2 million for Q1 2026.

  • Quarterly results put Capital Expenditures at $389.2 million for Q1 2026, up 363.47% from a year ago — trailing twelve months through Mar 2026 was $1.0 billion (up 478.23% YoY), and the annual figure for FY2025 was $729.0 million, up 667.68%.
  • Capital Expenditures reached $389.2 million in Q1 2026 per CORZ's latest filing, up from $279.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $389.2 million in Q1 2026 and bottomed at -$62.3 million in Q4 2022.
  • Median Capital Expenditures over the past 5 years was $22.5 million (2022), compared with a mean of $83.0 million.
  • The largest annual shift saw Capital Expenditures plummeted 99.89% in 2023 before it skyrocketed 247408.16% in 2025.
  • Over 5 years, Capital Expenditures stood at -$62.3 million in 2022, then skyrocketed by 118.68% to $11.6 million in 2023, then skyrocketed by 146.96% to $28.8 million in 2024, then skyrocketed by 871.03% to $279.2 million in 2025, then skyrocketed by 39.38% to $389.2 million in 2026.
  • Business Quant data shows Capital Expenditures for CORZ at $389.2 million in Q1 2026, $279.2 million in Q4 2025, and $244.5 million in Q3 2025.